Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Cereblon harnesses Myc-dependent bioenergetics and activity of CD8+ T lymphocytes.
Journal: Blood
Published: September 11, 2019
Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon.
Journal: The Journal of biological chemistry
Published: September 13, 2017
Emerging immunosuppressive drugs in myelodysplastic syndromes.
Journal: Expert opinion on emerging drugs
Published: November 21, 2012
Reversal of T-cell tolerance in myelodysplastic syndrome through lenalidomide immune modulation.
Journal: Leukemia
Published: December 24, 2011
Molecular action of lenalidomide in lymphocytes and hematologic malignancies.
Journal: Advances in hematology
Published: November 16, 2011
Showing 1-6 of 6
Last Updated: 09/26/2026